Fcγ receptors in autoimmune diseases

European Journal of Clinical Investigation

Volumn 31, Issue 9, 2001, Pages 821-831

  Fossati, G ^a   Bucknall, R C ^b   Edwards, S W ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Autoimmune diseases; FC receptors; IgG

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; ISOPROTEIN; RECEPTOR SUBTYPE;

ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNE DISEASE; CELL FUNCTION; CELLULAR IMMUNITY; GENETIC POLYMORPHISM; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; MICROBIAL IMMUNITY; MOLECULAR RECOGNITION; OPSONIZATION; PATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; REVIEW; GENETICS; IMMUNOLOGY;

AUTOIMMUNE DISEASES; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 0035542685     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00881.x     Document Type: Review

References (120)

1. Fc receptors
2. The molecular dissection of FcγR mediated phagocytosis
3. Fc receptor biology
4. Three genes for the human high affinity Fc receptor for IgG (FcγRI) encode four distinct transcription products
5. Structural bases of Fc-γ receptor functions
6. Human IgG Fc receptor heterogeneity: Molecular aspects and clinical implications
7. Chromosomal mapping of the high affinity FcγR gene
8. Structural and functional polymorphism of human Fc receptors for IgG
9. Molecular characterization of six variant FcγR class I (CD64) transcripts
10. The high-affinity FcγRI on PMN. Regulation of expression and signal transduction
11. Association of the high-affinity receptor for IgG (FcγRI) with the γ-subunit of the IgE receptor
12. Physical association between the high-affinity IgG receptor (FcγRI) and the γ-subunit of the high-affinity IgE receptor (FcεRIγ)
13. Biology of human IgG Fc receptors
14. Expression of the high responder/non-responder human FcγRII. Analysis by PCR and transfection into FcR-COS cells
15. Polymorphism of the human FcγRII (CD32): Molecular basis and functional aspects
16. The human low affinity immunoglobulin G FcγRIII-A and III-B genes. Molecular characterization of the promoter regions
17. Fc receptors and their interactions with immunoglobulins
18. The PI-linked receptor FcγRIII is released on stimulation of neutrophils
19. The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria
20. The FcγR of natural killer cells is a phospholipid-linked membrane protein
21. Membrane anchoring of a human IgG Fc receptor (CD16) determined by a single amino acid
22. A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of FcγRIII
23. The 40-kDa Fcγ receptor (FcRII) on human neutrophils is essential for the IgG-induced respiratory burst and IgG-induced phagocytosis
24. Effect of dibutyryl cyclic AMP and IFN-γ on FcγR expression on eosinophils
25. Induction of phosphatidylinositol-linked FcγRIII expression on an eosinophilic cell line, EoL-1, by dibutyryl cyclic AMP and IFN-γ
26. IFN-γ induces expression of FcγRIII (CD16) on human eosinophils
27. Defect in the membrane expression of high affinity 72-kD FcγR on phagocytic cells in four healthy subjects
28. Molecular basis for a familial defect in phagocyte expression of IgG receptor I (CD64)
29. Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: A study of 21 individuals from 14 families
30. Effect of allotype on activation of neutrophils by FcγRIIIB cross-linking
31. The NA 'null' phenotype of a young man is caused by an FcγRIIIB gene deficiency while the products of the neighboring FcγRIIA and FcγRIIIA genes are present
32. Frequency of the polymorphonuclear neutrophil FcγRIII deficiency in the French population and its involvement in the development of neonatal alloimmune neutropenia
33. Fc receptors: Rubor redux
34. An abnormality of the gene that encodes neutrophil FcγRIII in a patient with systemic lupus erythematosus
35. Alternative membrane forms of FcγRIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions
36. FcγRIIa (CD32) polymorphism in fulminant meningococcal septic shock in children
37. Polymorphism of IgG Fc receptors in meningococcal disease
38. FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans
39. FcγRIIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections
40. Phagocytosis mediated by three distinct Fcγ receptor classes on human leukocytes
41. Human FcγRII, in the absence of other Fcg receptors, mediates a phagocytic signal
42. Allelic polymorphisms of human FcγRIIA and FcγRIIIB. Independent mechanisms for differences in human phagocyte function
43. 2 binding
44. A single amino acid distinguishes the high-responder from the low-responder form of FcγRII on human monocytes
45. 2
46. Molecular basis for a polymorphism of human FcγRII (CD32)
47. Molecular basis for a polymorphism involving FcγRII on human monocytes
48. Variant genotypes of the low-affinity Fcγ receptors in two control populations and a review of low-affinity FcγR polymorphisms in control and disease populations
49. Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele specific oligonucleotide probes
50. Isolation and expression of cDNA clones encoding a human receptor for IgG (FcγRII)
51. Structure and expression of human IgG FcγRII (CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes
52. 2
53. 2-mediated bacterial phagocytosis by neutrophils
54. Crucial role of FcγRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera
55. 2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans
56. The monoclonal antibody 41H16 detects the Leu 4 responder form of human FcγRII
57. Genetic diversity in human FcγRII for IgG: FcγRIIA ligand-binding polymorphism
58. 3-opsonized bacteria and erythrocytes
59. 2 in man
60. Bacterial meningitis in the United States 1986: Report of a multistate surveillance study
61. Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae
62. The role of FcγR polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals
63. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease
64. Involvement of FcγRIIIA genotypes in susceptibility to rheumatoid arthritis
65. - 48L/R/H phenotype
66. Relevance of FcγRIIIa-158V-F polymorphism to recurrence of adult periodontitis in Japanese patients
67. Biallelic neutrophil NA-antigen system is associated with a polymorphism on the phospho-inositol-linked FcγRIII (CD16)
68. Characterization of polymorphic forms of FcγRIII on human neutrophils
69. Characterization of a new alloantigen (SH) on the human neutrophil FcγRIIIb
70. Sequences of complementary DNAs that encode the NA1 and NA2 forms of FcγRIII on human neutrophils
71. FcγRIII on human neutrophils. Allelic variants have functionally distinct capacities
72. FcγRIIIb enhances FcγRIIa function in an oxidant-dependent and allele-sensitive manner
73. Evaluation of human FcγRIIA (CD32) and FcγRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA
74. Alloimmune neonatal neutropenia resulting from immunization to a high-frequency antigen on the granulocyte FcγRIII
75. Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia
76. Autoimmune neutropenia
77. Autoimmune neutropenia of infancy
78. Neutrophil antibodies
79. Transfusion-related acute lung injury
80. NA gene frequencies in the German population, determined by polymerase chain reaction with sequence-specific primers
81. Neutrophil-specific antigens and gene frequencies in Japanese
82. Frequencies of neutrophil-specific antigens among Chinese in Taiwan
83. Autoimmune neutropenia: Clinical and laboratory studies in 143 patients
84. 3 subclass responses to two streptococcal protein antigens in man: Analysis of antibodies to streptolysin O and M protein using standardized subclass-specific enzyme-linked immunosorbent assays
85. IgG receptor polymorphisms: Risk factors for disease
86. FcγR type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups
87. FcγRIIa polymorphism in human immunodeficiency virus-infected children with invasive pneumococcal disease
88. Association of human FcγRIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease
89. FcγRIIa polymorphism in systemic lupus erythematosus (SLE): No association with disease
90. Overrepresentation of the Fcγ receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis
91. Abnormal distribution of FcγR type IIa polymorphisms in Korean patients with systemic lupus erythematosus
92. FcγRIIa polymorphism in systemic lupus erythematosus
93. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus
94. IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis
95. Clinical features of systemic lupus erythematosus
96. Cross-sectional analysis of the differences between patients with systemic lupus erythematosus in England, Brazil and Sweden
97. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus
98. Low-molecular weight C1q-binding IgG in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q
99. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus
100. Fcγ receptor polymorphisms in Wegener's granulomatosis: Risk factors for disease relapse
101. Relevance of IgG Fc receptor polymorphism to recurrence of adult periodontitis in Japanese patients
102. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease
103. Function of human FcγRIIA and FcγRIIIB
104. FcγRIII induces actin polymerization in human neutrophils and primes phagocytosis mediated by FcγRII
105. IgM anti-FcγR autoantibodies trigger neutrophil degranulation
106. Evidence for cross-regulation of FcγRIIIB (CD16) receptor-mediated signaling by FcγRII (CD32) expressed on polymorphonuclear neutrophils
107. Convergence of FcγRIIA and FcγRIIIB signaling pathways in human neutrophils
108. Neutrophil-specific antigen and gene frequencies in the French population
109. Determination of neutrophil antigen gene frequencies in five ethnic groups by polymerase chain reaction with sequence-specific primers
110. Neutrophil antigen (FcγRIIIB) SH gene frequencies in six racial groups
111. FcγRIIIB polymorphism: Evidence that NA1/NA2 and SH are located in two closely linked loci and that the SH allele is linked to the NA1 allele in the Danish population
112. 1 class in patients with systemic lupus erythematosus (SLE)
113. Neutrophil function in patients with primary Sjogren's syndrome: Relation to infection propensity
114. Polymorphonuclear leucocyte function in rheumatoid arthritis
115. Phagocytosis and intracellular killing of Staphylococcus aureus by polymorphonuclear cells from synovial fluid of patients with rheumatoid arthritis
116. Phagocytosis and intracellular killing by polymorphonuclear cells from patients with rheumatoid arthritis and Felty's syndrome
117. Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity IgG receptor, FcγRI (CD64): Role of immune complexes and cytokines in induction of receptor expression
118. Expression of FcγRIII in neutrophils in rheumatoid arthritis
119. Neutrophil functions in rheumatoid arthritis
120. Anti-FcγRIII autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid